Our Approach

The gap between dollars invested and dollars raised in the medical device and diagnostic sector has proven significant and growing; this funding gap has occurred at a time when many late-stage companies are requiring more capital to move successfully from concept to launch, and when fewer options are available to finance them. The market environment has proven challenging for both medical technology companies and their investors, and has provided SightLine with both opportunity and deal flow.

We have completed financing transactions with a broad group of constituents, including venture capital funds, corporations, hedge funds, and individuals.

Our investment process and the options we provide are beneficial to all parties including the existing investor who is seeking financial alternatives, the portfolio company and management team who are seeking to complete a fully subscribed financing round and the co-investors who want to maintain an intact syndicate or add a new investor with deep medical technology experience and fresh capital.